舰船燃气轮机高压涡轮动叶多维热耦合设计方法

针对舰船燃气轮机复杂高效冷却叶片设计,基于压力修正算法建立冷却叶片一维管网设计方法;通过快速求解可压缩边界层微分方程获得叶片外换热边界,基于参数化的叶片网格生成方法,采用全隐式有限体积的固体导热求解方法,构建了冷却叶片的耦合传热模型,开发了耦合传热计算程序。对某高压涡轮动叶进行多维热耦合设计,确定冷却流路及冷气分布,通过三维气热耦合计算验证了设计方案的可行性,通过对比分析验证了多维热耦合设计方法对主要流通单元的流量、压力误差小于5%,具备较高的工程应用价值。     

A novel low-latency DRAM based on the bitline-discharge rate

As well known by computer architects, the performance gap between the processor and the memory has been increasing over the years. This causes what is known as the memory wall. In order to alleviate the problem, a novel fast readout scheme is proposed in this article for the single-transistor single-capacitor dynamic random-access memory (1T-1C DRAM) cells. The proposed scheme works in the current domain in which the difference between the discharging rates of the bitline in the cases of ‘1’ and ‘0’ readings is detected. The proposed scheme is analysed quantitatively and compared with the conventional readout scheme. It is verified by simulation adopting the 45 nm CMOS Berkley predictive-technology model (BPTM) and shows 44 and 7.7% reductions in the average read-access and cycle times, respectively, as compared to the conventional readout scheme. It is also shown that the power is saved according to the proposed scheme if the probability of occurrence of ‘0’ storage exceeds 66.7%. This minimum value can be alleviated, however, at the expense of a smaller saving in the average read-access time. The impacts of process variations and technology scaling are also taken into account.     

Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases

Inflammatory processes are triggered by the fibrinolytic enzyme plasmin. Tissue-type plasminogen activator, which cleaves plasminogen to plasmin, can be activated by the cross-β-structure of misfolded proteins. Misfolded protein aggregates also represent substrates for plasmin, promoting their degradation, and are potent platelet agonists. However, the regulation of plasmin-mediated platelet activation by misfolded proteins and vice versa is incompletely understood. In this study, we hypothesize that plasmin acts as potent agonist of human platelets in vitro after short-term incubation at room temperature, and that the response to thrombospondin-1 and the bona fide misfolded proteins Eap and SCN⁻-denatured IgG interfere with plasmin, thereby modulating platelet activation. Plasmin dose-dependently induced CD62P surface expression on, and binding of fibrinogen to, human platelets in the absence/presence of plasma and in citrated whole blood, as analyzed by flow cytometry. Thrombospondin-1 pre-incubated with plasmin enhanced these plasmin-induced platelet responses at low concentration and diminished them at higher dose. Platelet fibrinogen binding was dose-dependently induced by the C-terminal thrombospondin-1 peptide RFYVVMWK, Eap or NaSCN-treated IgG, but diminished in the presence of plasmin. Blocking enzymatically catalyzed thiol-isomerization decreased plasmin-induced platelet responses, suggesting that plasmin activates platelets in a thiol-dependent manner. Thrombospondin-1, depending on the concentration, may act as cofactor or inhibitor of plasmin-induced platelet activation, and plasmin blocks platelet activation induced by misfolded proteins and vice versa, which might be of clinical relevance.     

碱性添加剂在钛硅分子筛/H2O2催化丙烯环氧化反应中的作用

考察了反应溶液中碱性添加剂{氨水（NH₄OH）、氢氧化钠（NaOH）、碳酸钠（Na₂CO₃）、碳酸铵[(NH₄)₂CO₃]和四甲基氢氧化铵（TMAOH）}及其浓度对钛硅分子筛（TS-1）催化丙烯环氧化反应性能的影响，并采用紫外拉曼光谱（UV-Raman）与气相色谱（GC）联用原位分析（Raman-GC）碱性添加剂的作用机理。结果表明：反应体系中添加碱性添加剂可有效改善TS-1催化丙烯环氧化反应的选择性。不同碱性添加剂对TS-1催化丙烯环氧化活性和稳定性影响不同，NaOH、Na₂CO₃和TMAOH的添加造成催化活性和稳定性降低。NH₄OH或(NH₄)₂CO₃作为添加剂改善环氧化反应选择性的同时提高了反应稳定性，其中以(NH₄)₂CO₃效果最佳。添加(NH₄)₂CO₃浓度为8.0×10^-4mol/L时，TS-1催化丙烯环氧化在固定床反应器上连续运行336h时，X(H₂O₂)仍保持在90%以上。原位Raman-GC分析发现，反应体系中NH₄OH和(NH₄)₂CO₃添加可加快反应活性中间体Ti-OOH(η²)基团的生成，促进反应产物从活性中心快速扩散，从而提高丙烯环氧化反应选择性和稳定性。     

Distinctive Microbial Signatures and Gut-Brain Crosstalk in Pediatric Patients with Coeliac Disease and Type 1 Diabetes Mellitus

Coeliac disease (CD) and Type 1 diabetes mellitus (T1DM) are immune-mediated diseases. Emerging evidence suggests that dysbiosis in the gut microbiome plays a role in the pathogenesis of both diseases and may also be associated with the development of neuropathy. The primary goal in this cross-sectional pilot study was to identify whether there are distinct gut microbiota alterations in children with CD (n = 19), T1DM (n = 18) and both CD and T1DM (n = 9) compared to healthy controls (n = 12). Our second goal was to explore the relationship between neuropathy (corneal nerve fiber damage) and the gut microbiome composition. Microbiota composition was determined by 16S rRNA gene sequencing. Corneal confocal microscopy was used to determine nerve fiber damage. There was a significant difference in the overall microbial diversity between the four groups with healthy controls having a greater microbial diversity as compared to the patients. The abundance of pathogenic proteobacteria Shigella and E. coli were significantly higher in CD patients. Differential abundance analysis showed that several bacterial amplicon sequence variants (ASVs) distinguished CD from T1DM. The tissue transglutaminase antibody correlated significantly with a decrease in gut microbial diversity. Furthermore, the Bacteroidetes phylum, specifically the genus Parabacteroides was significantly correlated with corneal nerve fiber loss in the subjects with neuropathic damage belonging to the diseased groups. We conclude that disease-specific gut microbial features traceable down to the ASV level distinguish children with CD from T1DM and specific gut microbial signatures may be associated with small fiber neuropathy. Further research on the mechanisms linking altered microbial diversity with neuropathy are warranted.     

TGFβ-1 Induced Cross-Linking of the Extracellular Matrix of Primary Human Dermal Fibroblasts

Excessive cross-linking is a major factor in the resistance to the remodelling of the extracellular matrix (ECM) during fibrotic progression. The role of TGFβ signalling in impairing ECM remodelling has been demonstrated in various fibrotic models. We hypothesised that increased ECM cross-linking by TGFβ contributes to skin fibrosis in Systemic Sclerosis (SSc). Proteomics was used to identify cross-linking enzymes in the ECM of primary human dermal fibroblasts, and to compare their levels following treatment with TGFβ-1. A significant upregulation and enrichment of lysyl-oxidase-like 1, 2 and 4 and transglutaminase 2 were found. Western blotting confirmed the upregulation of lysyl hydroxylase 2 in the ECM. Increased transglutaminase activity in TGFβ-1 treated ECM was revealed from a cell-based assay. We employed a mass spectrometry-based method to identify alterations in the ECM cross-linking pattern caused by TGFβ-1. Cross-linking sites were identified in collagens I and V, fibrinogen and fibronectin. One cross-linking site in fibrinogen alpha was found only in TGFβ-treated samples. In conclusion, we have mapped novel cross-links between ECM proteins and demonstrated that activation of TGFβ signalling in cultured dermal fibroblasts upregulates multiple cross-linking enzymes in the ECM.     

Effect of α-Lipoic Acid on the Development of Human Skin Equivalents Using a Pumpless Skin-on-a-Chip Model

Owing to the prohibition of cosmetic animal testing, various attempts have recently been made using skin-on-a-chip (SOC) technology as a replacement for animal testing. Previously, we reported the development of a pumpless SOC capable of drug testing with a simple drive using the principle that the medium flows along the channel by gravity when the chip is tilted using a microfluidic channel. In this study, using pumpless SOC, instead of drug testing at the single-cell level, we evaluated the efficacy of α-lipoic acid (ALA), which is known as an anti-aging substance in skin equivalents, for skin tissue and epidermal structure formation. The expression of proteins and changes in genotyping were compared and evaluated. Hematoxylin and eosin staining for histological analysis showed a difference in the activity of fibroblasts in the dermis layer with respect to the presence or absence of ALA. We observed that the epidermis layer became increasingly prominent as the culture period was extended by treatment with 10 μM ALA. The expression of epidermal structural proteins of filaggrin, involucrin, keratin 10, and collagen IV increased because of the effect of ALA. Changes in the epidermis layer were noticeable after the ALA treatment. As a result of aging, damage to the skin-barrier function and structural integrity is reduced, indicating that ALA has an anti-aging effect. We performed a gene analysis of filaggrin, involucrin, keratin 10, integrin, and collagen I genes in ALA-treated human skin equivalents, which indicated an increase in filaggrin gene expression after ALA treatment. These results indicate that pumpless SOC can be used as an in vitro skin model similar to human skin, protein and gene expression can be analyzed, and it can be used for functional drug tests of cosmetic materials in the future. This technology is expected to contribute to the development of skin disease models.